Clay Page

Clay Page is currently serving as a Sales Operations Strategy Analyst at Parexel since May 2024, focusing on aligning Sales Operations activities with corporate strategies and ensuring timely delivery of actionable information to management. Prior to this role, Clay worked as a Venture Capital Analyst at Keystone Capital Partners LLC, conducting research on healthcare and biotechnology companies to evaluate their potential for success. Clay also gained research experience as a Research Assistant at James Madison University, where work involved studying the cardiomyocyte protein desmoplakin through cell culture and protein analysis. Clay holds a Master of Science in Biotechnology from Georgetown University and a Bachelor of Science in Biotechnology from James Madison University.